What is the use of elevat capsules?
Pharmaceutical Product Monograph: Elevat Capsules (Fluoxetine 20 mg)
In the pharmaceutical industry, Elevat is a brand of Fluoxetine Hydrochloride, a landmark Selective Serotonin Reuptake Inhibitor (SSRI). As a pharmacist and manufacturer, I classify this as the “Prototypical SSRI”—it revolutionized psychiatry due to its long half-life and favorable safety profile compared to older antidepressants.
At your WHO-GMP facility in Mumbai, Elevat (Fluoxetine) is a high-volume, staple SKU. While often manufactured by firms like Cipla or HAB Pharmaceuticals in India, it is a core product for any firm targeting Mental Health and Eating Disorder segments.
Therapeutic Profile: Primary Indications
Elevat is indicated for a broad range of psychological disorders in both adults and, in some cases, children.
| Indication | Clinical Context | Technical Rationale |
| Major Depressive Disorder (MDD) | Psychiatry | The primary use; helps lift mood, improve sleep, and increase energy levels. |
| Obsessive-Compulsive Disorder (OCD) | Psychiatry | Reduces the frequency and intensity of intrusive thoughts and repetitive behaviors. |
| Bulimia Nervosa | Eating Disorders | One of the few FDA-approved drugs for reducing binge-eating and purging activity. |
| Panic Disorder | Anxiety | Helps manage sudden episodes of intense fear and physical symptoms like heart palpitations. |
| PMDD | Gynaecology | Treats severe premenstrual irritability, bloating, and mood swings. |
Mechanism: Selective Serotonin Reuptake Inhibition
Elevat works by specifically increasing the “residence time” of serotonin in the brain’s neural gaps:
SERT Inhibition: It technically binds to the Serotonin Transporter (SERT) on the presynaptic neuron.
Blocking Reuptake: This prevents serotonin from being “recycled” back into the nerve cell.
Enhanced Signaling: With more serotonin available in the synaptic cleft, nerve signals associated with mood regulation are strengthened and sustained.
The “Long Half-Life” Advantage: Fluoxetine has an exceptionally long half-life ($4\text{–}6\text{ days}$ for the parent drug, and up to 16 days for its active metabolite, Norfluoxetine). This makes it very “forgiving” if a patient misses a single dose.
The Pharmacist’s “Technical Warning”
The “Wait-and-Watch” Period: Fluoxetine is slow. It technically takes 2 to 4 weeks to see initial mood improvements and up to 8 weeks for the full clinical effect.
The “Black Box” Warning: Like all antidepressants, it carries a warning for increased suicidal thoughts in children, adolescents, and young adults (under 25) during the initial phase.
Weight Changes: Unlike some other SSRIs, Fluoxetine is often “weight neutral” or can even cause minor weight loss initially, which is why it’s preferred for bulimia patients.
The “Washout” Rule: Due to its long half-life, you must wait at least 5 weeks after stopping Elevat before starting an MAOI (Monoamine Oxidase Inhibitor) to avoid fatal Serotonin Syndrome.
The Manufacturer’s Perspective: Technical & Export
From the CEO’s desk at Healthy Life Pharma / Healthy Inc:
The “Bulimia Market” USP: On your digital marketplace, highlight Elevat as a “Specialized Solution for Eating Disorders.” This is a specific niche that differentiates you from general “Anti-Anxiety” suppliers.
Stability: Fluoxetine is stable, but for Mumbai-based export, use Alu-Alu or high-grade PVC/PVDC blistering. Ensure your 20 mg capsules are protected from moisture to maintain the integrity of the hydrochloride salt.
The “Liquid” Alternative: In some export markets, a liquid/syrup version is popular for pediatric OCD. Consider this as a potential product line expansion for your Healthy Inc portfolio.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Fluoxetine 20 mg to support your registration in international B2B mental health tenders.